Personal prizes & awards national & international

  • 2015-2019: Awarded a VENI grant (Netherlands Organization for Scientific Research) Tumor Immunology, Radboud University Nijmegen
  • 2012-2017: KWF (Dutch Cancer Society) longterm fellowship Department of Immunobiology, Yale School of Medicine, USA and Tumor Immunology, Radboud University Nijmegen
  • 2012: EMBO short term fellowship Pathology & Immunology, Washington University, US.
  • 2011-2015: KWF grant (G.J. Adema, M. Ansems en J.W.M. Martens) 
  • 2009: Poster award Annual meeting NVvI
People Marleen Ansems

Contact

Marleen Ansems PhD
assistant professor

+31 (0)24 361 05 52
contact

Marleen Ansems assistant professor

After finishing my PhD at the department of Tumor Immunology in Nijmegen, I moved to the US in 2012 where I started working on a KWF fellowship studying the role of TAM receptors in anti-tumor immunity at the department of Immunobiology, Yale School of Medicine.

read more

Marleen Ansems assistant professor

After finishing my PhD at the department of Tumor Immunology in Nijmegen, I moved to the US in 2012 where I started working on a KWF fellowship studying the role of TAM receptors in anti-tumor immunity at the department of Immunobiology, Yale School of Medicine. In 2015 I moved back to the Netherlands. Currently I am still working on my KWF fellowship and working on a VENI grant where I am investigating the role of NR4A nuclear receptors in Dendritic Cells at the laboratory of Radiotherapy & OncoImmunology, department of Radiation Oncology.

Personal prizes & awards national & international

  • 2015-2019: Awarded a VENI grant (Netherlands Organization for Scientific Research) Tumor Immunology, Radboud University Nijmegen
  • 2012-2017: KWF (Dutch Cancer Society) longterm fellowship Department of Immunobiology, Yale School of Medicine, USA and Tumor Immunology, Radboud University Nijmegen
read more

Personal links


Field of study

Radiation Oncology

Radboud Institute for Molecular Life Sciences

Our main aim is to achieve a greater understanding of the molecular mechanisms of disease. By integrating fundamental and clinical research, we obtain multifaceted knowledge of (patho)physiological processes. read more